Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

Quantitative Aspects of Drug-Receptor Interaction

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

Factors Affecting Drug Response: Overview

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Air pollution and cause-specific mortality in EU: a review integrating meta-analysis and meta-regression.

Scientific reports·2026

Same author

Obesity, Air Pollution, and Epigenetic Modifications as Risk Factors for Asthma Phenotypes.

International journal of molecular sciences·2026

Same author

Crystalline Insights into Nasal Mucosa Inflammation and Remodeling: Unveiling Role of Galectin-10.

Biomolecules·2026

Same author

ISOMED - A Stable ISOtope database of MEDiterranean marine food web components.

Scientific data·2025

Same author

Control of Allergic Rhinitis and Asthma Test for Children (CARATkids): A systematic review and meta-analysis of its measurement properties.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2025

Same author

Unmasking Pediatric Asthma: Epigenetic Fingerprints and Markers of Respiratory Infections.

International journal of molecular sciences·2025

Search research articles

Related Experiment Video

Updated: Oct 30, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

A Methodological Framework to Discover Pharmacogenomic Interactions Based on Random Forests.

Salvatore Fasola¹, Giovanna Cilluffo¹, Laura Montalbano¹

¹Institute for Biomedical Research and Innovation, National Research Council, 90146 Palermo, Italy.

|July 2, 2021

Summary

This summary is machine-generated.

This study introduces a Random Forest framework to uncover pharmacogenomic interactions by analyzing genomic alterations and drug sensitivity data. The method identified 12 compounds sensitive to specific tumor alteration profiles, aiding drug-gene interaction discovery.

Keywords:

Random Forests cancer cell lines drug response genomic alterations pharmacogenomic interactions

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

Related Experiment Videos

Last Updated: Oct 30, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

Area of Science:

Genomics
Pharmacology
Computational Biology

Background:

Genomic alterations in tumors correlate with therapeutic responses.
Large datasets from projects like CCLE and GDSC offer opportunities for pharmacogenomic analysis.
Discovering drug-gene interactions is crucial for personalized medicine.

Purpose of the Study:

To develop a methodological framework for discovering pharmacogenomic interactions using Random Forests.
To correlate genomic alterations with drug sensitivity data from CCLE and GDSC.
To identify specific gene alterations that influence drug responses.

Main Methods:

Matched CCLE and GDSC databases for 648 cell lines.
Utilized 48,270 gene alterations (input) and 265 drug AUC values (outcomes).
Applied a three-step feature reduction to 501 alterations and Random Forest modeling.

Main Results:

Identified 12 compounds with sensitivity (CCC > 20) to specific alteration profiles within 56 minutes.
Assessed predictive performance using concordance correlation coefficient (CCC).
Determined influential alterations using permutation importance, revealing drug-gene interaction clues.

Conclusions:

The proposed Random Forest framework effectively mines pharmacogenomic interactions.
The findings provide insights into significant drug-gene relationships.
This methodology can accelerate the discovery of targeted therapies based on genomic profiles.